Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?

Gastroenterology. 2023 Jan;164(1):15-18. doi: 10.1053/j.gastro.2022.10.030. Epub 2022 Nov 9.

¹ Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy; Division of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: giovanni.brandi@unibo.it.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
³ Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy; Division of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

No abstract available

Publication types